Artículos del autor

solaci

Events

The EuroPCR 2023 is coming

EuroPCR 2023, one of the most important events in interventional cardiology, will be held in Paris, France,...
solaci -
Coronary disease

Left Main Coronary Artery Revascularization: Are Periprocedural Complications Significant?

In the field of percutaneous coronary intervention (PCI) and myocardial revascularization surgery (MRS), previous analyses have shown...
solaci -
Mitral valve

TriClip: Tricuspid Regurgitation Dedicated Device

Severe tricuspid regurgitation (TR) is difficult to manage and is associated to high morbimortality.  Surgical repair is complex...
solaci -
Institutional News

The most read scientific articles in interventional cardiology in February on our website

Below, we share February's most read scientific abstracts in interventional cardiology at solaci.org. Can Drug Coated Balloon Be...
solaci -
Institutional News

Watch Again How to Avoid Self-Sabotage in Interventional Cardiology – SOLACI-MIL-Medtronic Webinar

You can now relive our virtual event on how to avoid self-sabotage in Interventional cardiology, aimed at...
solaci -
Structural heart disease

COAPT: Promising 5-Year Outcomes

Secondary ischemic and non-ischemic mitral valve failure (SMR), produce left ventricle dilation, papillary muscle displacement, and impaired...
solaci -
Femoral

TAVR: Vascular Access in Patients with Peripheral Artery Disease, 1-Year Outcomes

At present, the transfemoral access (TFA) is the preferred approach when it comes to transcatheter aortic valve...
solaci -
Coronary disease

Vascular Ultrasound in Percutaneous Closure Devices: Subanalysis of the UNIVERSAL-Trial

Analysis of percutaneous closure device placement when choosing an ultrasound-guided vs. a fluoroscopy-guided femoral approach. Transradial access is...
solaci -